Haeggquist & Eck Announces Investigation of KemPharm, Inc.

Haeggquist & Eck, LLP has commenced an investigation into (“KemPharm”) (NASDAQ: KMPH) to determine whether KemPharm and its Officers and Directors have violated the federal securities laws. KemPharm is a clinical-stage specialty pharmaceutical company, discovers and [...]

By |2017-05-24T20:13:47-08:00September 30th, 2016|

Alreen Haeggquist Recognized Among “40 Under 40” by SD Metro Magazine

Haeggquist & Eck Managing Partner Alreen Haeggquist was recognized as one of SD Metro Magazine’s “40 Under 40” in a ceremony Friday, September 16. Haeggquist & Eck LLP, Alreen is dedicated to representing employees who have been wrongfully [...]

By |2017-05-24T20:14:02-08:00September 16th, 2016|